DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-12.82%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.55B
AUM Growth
+$2.55B
(-14%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
4.51%
Top 10 Holdings %
Top 10 Hldgs %
31.13%
Holding
150
New
29
Increased
31
Reduced
32
Closed
16
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$37.5M |
| 2 |
GSK
GSK
|
$34.8M |
| 3 |
Regenxbio
RGNX
|
$29.4M |
| 4 |
AET
Aetna Inc
AET
|
$29.1M |
| 5 |
AAC
AAC Holdings, Inc.
AAC
|
$28.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$82.8M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$38M |
| 3 |
Inogen
INGN
|
$26.8M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$24.9M |
| 5 |
Boston Scientific
BSX
|
$24.9M |
Sector Composition
| 1 | Healthcare | 69.73% |
| 2 | Financials | 4.83% |
| 3 | Technology | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $160M | 6.2% | 8,081,407 -4,178,468 | -34% | -$82.8M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $99.6M | 3.85% | 6,318,050 +545,000 | +9% | +$8.59M |
|
|
3
GSK
GSK
$79.9B
| $87.8M | 3.4% | 2,282,722 +906,000 | +66% | +$34.8M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $69.6M | 2.69% | 636,039 +266,300 | +72% | +$29.1M |
|
|
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.43B
| $66.4M | 2.57% | 4,072,809 | – | – |
|
|
DYAX
6
DELISTED
DYAX CORPORATION
DYAX
| $54.6M | 2.11% | 2,857,773 +374,266 | +15% | +$7.14M |
|
7
Vanda Pharmaceuticals
VNDA
$279M
| $54M | 2.09% | 4,784,157 | – | – |
|
8
DaVita
DVA
$9.85B
| $51.8M | 2% | 716,000 +80,000 | +13% | +$5.79M |
|
9
Viatris
VTRS
$12.3B
| $51.3M | 1.99% | 1,275,000 +404,000 | +46% | +$16.3M |
|
|
ALPN
10
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $48.4M | 1.87% | 3,732,412 | – | – |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $44.4M | 1.72% | 9,729,361 +200,000 | +2% | +$912K |
|
|
ADPT
12
DELISTED
Adeptus Health Inc.
ADPT
| $44M | 1.7% | 545,328 +181,328 | +50% | +$14.6M |
|
13
eHealth
EHTH
$118M
| $41.8M | 1.62% | 3,264,588 | – | – |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $41.3M | 1.6% | 483,000 +156,217 | +48% | +$13.4M |
|
|
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
| $38.5M | 1.49% | 463,457 -185,044 | -29% | -$15.4M |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $37.5M | 1.45% | +890,620 | New | +$37.5M |
|
17
Charles River Laboratories
CRL
$8.04B
| $36.9M | 1.43% | 581,188 -30,248 | -5% | -$1.92M |
|
|
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $35.7M | 1.38% | 391,122 +29,169 | +8% | +$2.67M |
|
|
AAC
19
DELISTED
AAC Holdings, Inc.
AAC
| $35.6M | 1.38% | 1,601,376 +1,298,349 | +428% | +$28.9M |
|
20
Teva Pharmaceuticals
TEVA
$21.1B
| $34.7M | 1.34% | 615,000 -31,000 | -5% | -$1.75M |
|
21
McKesson
MCK
$85.4B
| $34.4M | 1.33% | 185,646 +49,646 | +37% | +$9.19M |
|
|
UAM
22
DELISTED
Universal American Corp
UAM
| $33.7M | 1.3% | 4,930,787 +521,084 | +12% | +$3.56M |
|
|
INFI
23
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $33M | 1.28% | 3,910,721 +1,445,592 | +59% | +$12.2M |
|
|
24
Regenxbio
RGNX
$451M
| $29.4M | 1.14% | +1,336,542 | New | +$29.4M |
|
25
Pacira BioSciences
PCRX
$1.2B
| $28.9M | 1.12% | 702,485 +490,485 | +231% | +$20.2M |
|